Study Explores Effects of MRI Scans During Cancer Treatment
Dutch scientists have found that the majority of brain cancer patients who have repeated MRI scans of their brains in follow-up visits tolerate the sessions quite well. However, if given a choice, most cancer patients would avoid gadolinium-based contrast agents (GBCAs) in cases with diagnostically equivalent results. The research team published its results in the “Journal of Neuro-Oncology” in late March. According to the team, the study findings could allow clinicians to improve the care of patients diagnosed with primary brain tumors, particularly glioma. Gliomas are a deadly type of primary brain tumor that starts growing in the brain or…